Overview
Ibrahim Fazmin practices practicing medicine in Cambridge, United Kingdom.
His clinical expertise encompasses Atrial Fibrillation, Coronary Heart Disease, and Postmenopausal Osteoporosis.
He is actively involved in clinical research, co-authoring 21 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ibrahim T. Fazmin
Is Ibrahim T. Fazmin a top-rated expert for Atrial Fibrillation?
MediFind is an objective health platform that identifies experts based on real-world data. Ibrahim T. Fazmin is classified as an Experienced expert for Atrial Fibrillation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ibrahim T. Fazmin participate in research or clinical trials?
Yes. Ibrahim T. Fazmin has published 21 articles and abstracts on conditions like Atrial Fibrillation. You can view a list of Ibrahim T. Fazmin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Atrial FibrillationMr. Fazmin isExperienced. Learn about Atrial Fibrillation.
- Coronary Heart DiseaseMr. Fazmin isExperienced. Learn about Coronary Heart Disease.
- Postmenopausal OsteoporosisMr. Fazmin isExperienced. Learn about Postmenopausal Osteoporosis.